Novel Drug Delivers Long Term Cholesterol Reduction

A novel drug that dramatically lowers LDL cholesterol and needs to be administered only a few times a year has reached a new milestone. Positive results from a phase II study with the drug, now known as inclisiran, were reported at the American College of Cardiology meeting in Washington, DC and published simultaneously in the...Click here to continue reading...
Source: CardioBrief - Category: Cardiology Authors: Tags: People, Places & Events Prevention, Epidemiology & Outcomes cholesterol inclisiran LDL Medicines Company PCSK9 Source Type: blogs